Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study
Acta Psychiatrica Scandinavica · 2023
DOI: 10.1111/acps.13612 ↗At a glance
Kohortenstudie in Acta Psychiatrica Scandinavica, 2023. Written by Masaru Tsukahara and 10 co-authors. Institution: Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan. Major MEDLINE topics: Clozapine, Schizophrenia, Antipsychotic Agents. Cited 9 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Introduction
No study has investigated the impact of smoking habits and concomitant valproic acid (VPA) use on clinical outcomes in maintenance treatment with clozapine. Thus, we aimed to examine the effect of smoking habits and concomitant VPA use on relapse during the first year after discharge in patients with treatment‐resistant schizophrenia (TRS) receiving clozapine.
Methods
This retrospective cohort study included patients with TRS who were initiated on clozapine during hospitalization and discharged between April 2012 and January 2021 in two tertiary psychiatric hospitals in Japan. Relapse was defined as rehospitalization due to psychiatric exacerbation during the first year after discharge. A multivariable Cox proportional hazards regression analysis was performed to analyze the effect of smoking habits and concomitant VPA use on relapse. Subgroup analyses were also conducted to examine potential interactions between smoking habits and concomitant VPA use.
Results
Among the included 192 patients, 69 (35.9%) met the criteria of relapse. While smoking habits (adjusted hazard ratio [aHR], 2.27; 95% confidence interval [CI], 1.28–4.01; p < 0.01) independently increased the risk of relapse, a significant interaction for relapse risk was found between smoking habits and concomitant VPA use ( p ‐interaction = 0.015). Concomitant VPA use may be an effective modifier of the increased relapse risk associated with smoking habits. Among patients who smoked, those using VPA concomitantly exhibited a higher risk of relapse (aHR, 5.32; 95% CI, 1.68–16.9; p < 0.01) than those not using VPA (aHR, 1.41; 95% CI, 0.73–2.70; p = 0.30).
Conclusion
The findings suggest that the combination of smoking habits and concomitant VPA use may increase the risk of relapse after discharge. Future studies are required to elucidate the mechanisms underlying these findings, such as a decrease in clozapine blood levels.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.
- Department of Psychiatry, Zikei Hospital, Okayama, Japan.
- Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
ORCID profiles: Masaru Tsukahara, Ryuhei So, Shinichiro Nakajima, Norihito Yamada, Hiroyoshi Takeuchi
Cite
APA
Tsukahara, M., So, R., Yoshimura, Y., Yamashita, R., Yada, Y., Kodama, M., Nakajima, S., Kishi, Y., Takeda, T., Yamada, N., & Takeuchi, H. (2023). Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13612
Vancouver
Tsukahara M, So R, Yoshimura Y, Yamashita R, Yada Y, Kodama M, et al. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study. Acta Psychiatrica Scandinavica. 2023. doi:10.1111/acps.13612
BibTeX
@article{Tsukahara2023,
author = {Tsukahara, Masaru and So, Ryuhei and Yoshimura, Yusaku and Yamashita, Rieko and Yada, Yuji and Kodama, Masafumi and Nakajima, Shinichiro and Kishi, Yoshiki and Takeda, Toshihiko and Yamada, Norihito and Takeuchi, Hiroyoshi},
title = {Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study},
journal = {Acta Psychiatrica Scandinavica},
year = {2023},
doi = {10.1111/acps.13612}
}
EUVIMED